About the Kaposi Sarcoma Session
Kaposi sarcoma (KS) is a rare cancer that often manifests as lesions on the skin, mucous membranes, or internal organs. Historically associated with HIV/AIDS, KS can also occur in transplant recipients and elderly individuals. Recent research in cancer biology has shed light on the role of human herpesvirus 8 (HHV-8) in KS development, particularly in immunocompromised individuals. Immunotherapy, including checkpoint inhibitors, shows promise in treating advanced KS by bolstering the body's immune response against HHV-8-infected cells. Additionally, targeted therapies that inhibit angiogenesis, a process crucial for tumor growth, are being explored as potential treatments for KS. While advancements have improved outcomes for KS patients, further research is essential to develop more effective and targeted therapies, especially for those with advanced disease or limited treatment options.
Topics Covered in Kaposi Sarcoma
Herpesvirus Oncogenesis
HIV-Associated Disease
Classic & Endemic Forms
Transplant-Related Disease
Antiretroviral Therapy
Liposomal Chemotherapy
Related Scientific Sessions at CIOC 2027
Why Attend the Kaposi Sarcoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Kaposi Sarcoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Kaposi Sarcoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Kaposi Sarcoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Kaposi Sarcoma Conference 2027 — FAQs
What is the Kaposi Sarcoma track at CIOC 2027?
The Kaposi Sarcoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Kaposi Sarcoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Kaposi Sarcoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Kaposi Sarcoma are all welcome — whether presenting or attending.
Can I present my research in the Kaposi Sarcoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Kaposi Sarcoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Kaposi Sarcoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.